Australia markets closed

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.24-0.53 (-2.06%)
At close: 04:00PM EDT
25.94 +0.70 (+2.77%)
After hours: 07:28PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts9111011
Avg. Estimate-0.92-0.94-3.25-3.03
Low estimate-1.18-1.27-5.03-4.85
High estimate-0.74-0.77-1.58-1.84
Year ago EPS-0.92-0.98-3.95-3.25
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5779
Avg. Estimate11.63M3.6M169.28M193M
Low estimateN/AN/A12.9M116.1M
High estimate52M15M459.78M256.97M
Year ago sales1.83MN/A9.3M169.28M
Sales growth (year/est)536.90%N/A1,719.60%14.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.83-0.83-0.82-0.91
Actual EPS-0.92-0.98-1.08-0.96
Difference-0.09-0.15-0.26-0.05
Surprise %-10.80%-18.10%-31.70%-5.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.92-0.94-3.25-3.03
7 days ago-0.92-0.94-3.25-3.03
30 days ago-0.94-0.97-3.47-3.08
60 days ago-0.83-0.93-3.43-3.12
90 days ago-0.95-0.96-3.54-2.84
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBBIOIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.4.10%N/AN/AN/A
Current year17.70%N/AN/AN/A
Next year6.80%N/AN/AN/A
Next 5 years (per annum)67.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A